In Vitro Anti-proliferative and Anti-invasive Role of Amino-terminal Fragment of Urokinase-type Plasminogen Activator on 8701-BC Breast Cancer Cells

European Journal of Cancer

Volumn 32, Issue 4, 1996, Pages 702-707

  Luparello, C ^a   Del Rosso, M ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

8701 BC cells; Breast carcinoma; Cell invasion; Cell proliferation; Urokinase

Indexed keywords

PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CARCINOMA; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; CULTURE MEDIA; HUMANS; NEOPLASM INVASIVENESS; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030007538     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00657-5     Document Type: Article

References (45)

1. Danø K, Andreasen PA, Grondal-Hansen J, Kristensen PI, Nielsen LS, Skriver L. Plasminogen activator, tissue degradation and cancer. Adv Cancer Res 1985, 44, 139-166.
2. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73, 161-195.
3. Sappino AP, Busso N, Belin D, Vassalli JD. Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res 1987, 47, 4043-4046.
4. Ossowski L. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of surface-bound urokinase. J Cell Biol 1988, 107, 2437-2445.
5. Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological function. Annu Rev Cell Biol 1988, 4, 92-126.
6. Yagel S, Ranjit SP, Jeffrey JJ, Lala PK. Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol 1988, 136, 455-462.
7. Pereyra-Alfonso S, Solarz G, Bal De Kier Joffè E. Urokinase-type plasminogen activator activity increases during the growth of two murine mammary adenocarcinomas with different metastasizing abilities. Clin Exp Metastasis 1992, 10, 395-401.
8. Schmitt M, Goretzki L, Janicke F, et al. Biological and clinical relevance of the urokinase-rype plasminogen activator (uPA) in breast cancer. Biomed Biochim Acta 1991, 50, 731-741.
9. Sumiyoshi K, Serizawa K, Urano T, Takada Y, Takada A, Baba S. Plasminogen activator system in human breast cancer. Int J Cancer 1992, 50, 345-348.
10. Bouchet C, Spyratos F, Martin PM, Hacene K, Gentile A, Oglobine J. Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. Br J Cancer 1994, 69, 398-405.
11. Danø K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C. The urokinase-receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994, 8 (suppl. 1), 189-203.
12. Needham GK, Sherbet GV, Farndon JR, Harris AL. Binding of urokinase to specific receptors sites on human breast cancer membranes. Br J Cancer 1987, 55, 13-16.
13. Blasi F. Urokinase and urokinase-receptor: a paracrine-autocrine system regulating cell migration and invasiveness. BioEssays 1993, 15, 105-111.
14. Keski-Oja J, Lohi J, Tuuttila A, Tryggvason K, Vartio T. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res 1992, 202, 471-476.
15. Gudewicz PW, Gilboa N. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem Biophys Res Commun 1987, 147, 1176-1181.
16. Fibbi G, Ziehe M, Morbidelli L, Magnelli L, Del Rosso M. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res 1988, 179, 385-395.
17. Del Rosso M, Fibbi G, Dini G, et al. Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. J Invest Dermatol 1990, 94, 310-316.
18. Del Rosso M, Pedersen N, Fibbi G, et al. Selective localization of receptors for urokinase amino-terminal fragments at substratum contact sites of an in vitro established line of human epidermal cells. Exp Cell Res 1992, 203, 427-434.
19. Del Rosso M, Anichini E, Pedersen N, et al. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun 1993, 190, 347-352.
20. Rabbani SA, Desjardins J, Bell AW, et al. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem Biophys Res Commun 1990, 173, 1058-1064.
21. Rabbani SA, Mazar AP, Bernier SM, et al. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 1992, 267, 14151-14156.
22. Odekon LE, Sato Y, Rifkin DB. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 1992, 150, 258-263.
23. Luparello C, Ginty AF, Gallagher JA, Pucci-Minafra I, Minafra S. Transforming growth factor β1, β2, β3, urokinase and parathyroid hormone-related peptide expression by 8701-BC cells and clones. Differentiation 1993, 55, 73-80.
24. Minafra S, Morello V, Glorioso F, et al. A new cell line (8701-BC) from primary ductal infiltrating carcinoma of the human breast. Br J Cancer 1989, 60, 185-192.
25. Pucci-Minafra I, Minafra S, Alessandro R, Faccini AM. An ultrastructural evaluation of cell heterogeneity in invasive ductal carcinomas of the human breast. I. An in vitro study. J Submicrosc Cytol Pathol 1989, 21, 488-499.
26. Roldan AL, Cubellis MV, Masucci MT, et al. Cloning and expression of the receptor for urokinase plasminogen activator, a central molecule in cell surface. EMBOJ 1990, 9, 467-474.
27. Alessandro R, Minafra S, Pucci-Minafra I, et al. Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC. Int J Cancer 1993, 55, 250-255.
28. Anichini E, Fibbi G, Pucci M, Caldini M, Chevanne M, Del Rosso M. Production of second messenger following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Exp Cell Res 1994, 213, 438-448.
29. 2-terminal domain of the urokinase receptor. FEBS Lett 1991, 288, 233-236.
30. Albini A, Iwamoto Y, Kleinman K, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47, 3239-3245.
31. Pucci-Minafra I, Luparello C, Aquino A, et al. OF/LB collagen promotes chemoinvasion of breast cancer cells and directs epithelial cell migration into granulation tissue of experimental dermal wounds. Int J Oncol 1995, 6, 1015-1020.
32. Luparello C, Burtis WJ, Raue F, Birch M, Gallagher JA. Parathyroid hormone-related peptide and 8701-BC cell growth and invasion in vitro. Mol Cell Endocrinol 1995, 111, 225-232.
33. Kleiner DE Jr, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteinases. Curr Opin Cell Biol 1993, 5, 891-897.
34. 2-terminal aminoacid sequence and glycosilation variants. J Biol Chem 1990, 265, 6453-6460.
35. Stoppelli MP, Corti A, Soffientini A, Cassani G, Glasi F, Assoian RK. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 1985, 8, 4939-4943.
36. Stoppelli MP, Tacchetti C, Cubellis MV, et al. Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell 1986, 45, 675-684.
37. Kircheier JC, Wojta J, Christ G, Binder BR. Functional inhibition of endogenously-produced urokinase decreases cell proliferation in a human melanoma cell line. Proc Natl Acad Sci USA 1989, 86, 5424-5428.
38. Busso N, Masur Sk, Lazega D, Waxman S, Ossowski L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 1994, 126, 259-270.
39. De Petro G, Copeta A, Barlati S. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res 1994, 213, 286-294.
40. He CJ, Rebibou JM, Peraldi MN, Meulders Q, Rondeau E. Growth factor-like effect of urokinase-type plasminogen activator in human renal cells. Biochem Biophys Res Commun 1991, 176, 1408-1416.
41. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH. Identification of multiple active growth factors in basement membrane matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 1992, 202, 1-8.
42. MacKay AR, Gomez DE, Cottam DW, Rees RC, Nason AM, Thorgeirsson P. Identification of the 72-kDa (MMP-2) and 92 kDa (MMP-9) gelatinase/type IV collagenase in preparations of laminin and matrigel. BioTechniques 1993, 15, 1048-1051.
43. Ossowski L, Reich E. Antibodies to plasminogen activator inhibit tumor metastasis. Cell 1983, 35, 611-619.
44. Kobayashi H, Ohi H, Shinohara H, et al. Saturation of tumor cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membrane invasion. Br J Cancer 1993, 67, 537-544.
45. Lu H, Yeh P, Guitton JD, et al. Blockage of the urokinase receptor on the cell surface: construction and characterization of a hybrid protein consisting of the N-terminal fragment of human urokinase and human albumin. FEBS Lett 1994, 356, 56-59.